People · Operator
Named in public records as an officer, director or promoter · active 2024–2024 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Nectero Medical Inc | — | Biotechnology | Series B | $52.5M | $259.4M | 2024 |
Jack Springer at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Jack Springer on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Bruce Roberts | 1 | 9 |
| Robert Whirley | 1 | 4 |
| Anil Dasu | 1 | 2 |
| Colin Morrison | 1 | 2 |
| John Springer | 1 | 2 |
| Bryan Ziegler | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.